Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Inventory, Finished Goods, Gross

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Inventory, Finished Goods, Gross

EMERGENT BIOSOLUTIONS INC. (EBS) had Inventory, Finished Goods, Gross of $4.94 million as of 2012-09-30, per its 10-Q filed 2012-11-01.

Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net

us-gaap:InventoryFinishedGoods · last filed 2012-11-01

  • 2012-09-30: Inventory, Finished Goods, Gross $4.94M.
  • 2012-06-30: Inventory, Finished Goods, Gross $3.70M.
  • 2011-12-31: Inventory, Finished Goods, Gross $2.20M.
Period endInventory, Finished Goods, Gross
2012-09-30$4.94M
10-Q · filed 2012-11-01
2012-06-30$3.70M
10-Q · filed 2012-08-03
2011-12-31$2.20M
10-Q · filed 2012-11-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45